< Back to previous page
Researcher
Shannen Deconinck
- Disciplines:Biochemistry and metabolism, Cardiac and vascular medicine, Medical biochemistry and metabolism
Affiliations
- Chemistry, Kulak Kortrijk Campus (Department)
Member
From1 Sep 2015 → Today
Projects
1 - 3 of 3
- Towards a novel targeted therapy to treat bleeding after heart pump implantation in patients with heart failure.From1 Jun 2023 → TodayFunding: IOF - technology validation in lab
- A novel targeted therapy to treat bleeding in patients with a left ventricular assist device.From1 May 2023 → TodayFunding: IOF - mandates
- Towards a novel therapy to treat bleeding after left ventricular assist device implantation in patients with heart failure.From1 Jan 2016 → 22 Feb 2021Funding: FWO Strategic Basic Research Grant
Publications
1 - 6 of 6
- ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation(2022)
Authors: Shannen Deconinck, Christophe Vandenbriele, Bart Meyns, Claudia Tersteeg, Steven Jacobs, Simon De Meyer, Karen Vanhoorelbeke
Pages: 2797 - 2809 - Plasma and rhADAMTS13 reduce trauma-induced organ failure by restoring the ADAMTS13-VWF axis(2021)
Authors: Charlotte Dekimpe, Shannen Deconinck, Karen Vanhoorelbeke
Pages: 3478 - 3491 - Inhibition of adamts13: a novel therapy to treat mechanical circulatory support-induced acquired von willebrand syndrome(2020)
Authors: Shannen Deconinck, Bart Meyns, Simon De Meyer, Karen Vanhoorelbeke
Pages: 3836 - 3836 - Acquired von Willebrand syndrome in patients on long-term left ventricular assist device support: Results of a Belgian center(2019)
Authors: Shannen Deconinck, Claudia Tersteeg, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 77 - 80 - Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome
Authors: Shannen Deconinck, Claudia Tersteeg, Hans Deckmyn, Simon De Meyer, Karen Vanhoorelbeke
Pages: 762 - 766 - Towards a novel therapy to treat bleeding after left ventricular assist device implantation in patients with heart failure
Authors: Shannen Deconinck, Karen Vanhoorelbeke, Nick Geukens, Simon De Meyer, Claudia Tersteeg
Patents
1 - 7 of 7
- Haemorrhagic disorder due to ventricular assist device (Inventor)
- Humanised adamts13 binding antibodies (Inventor)
- Anti adamts13 antibodies and their use for treatment or prevention of haemorrhagic disorders due to ventricular assist device (Inventor)
- Humanised adamts13 binding antibodies (Inventor)
- Haemorrhagic disorder due to ventricular assist device (Inventor)
- Humanised adamts13 binding antibodies (Inventor)
- Anti adamts13 antibodies and their use for treatment or prevention of haemorrhagic disorders due to ventricular assist device (Inventor)